Apr 8 |
NextCure and LCB Present Preclinical Data on B7-H4 Antibody Drug Conjugate at AACR 2024
|
Apr 4 |
NextCure Appoints Dr. Rakesh Dixit to Scientific Advisory Board
|
Apr 2 |
NextCure to Present at 23rd Annual Needham Virtual Healthcare Conference
|
Mar 27 |
Will NextCure (NASDAQ:NXTC) Spend Its Cash Wisely?
|
Mar 21 |
NextCure GAAP EPS of -$2.25 beats by $0.02
|
Mar 21 |
NextCure to lay off 37% of staff, dial back research plans
|
Mar 21 |
NextCure Provides Business Update and Reports Full Year 2023 Financial Results
|
Mar 5 |
NextCure Publishes Preclinical Data Demonstrating Function of FLRT3 as a T Cell Inhibitor in Science Advances
|
Jan 18 |
NextCure Presents Preclinical Data on a Novel Therapeutic Candidate Targeting VSTM-1 for the Treatment of Progressive Inflammatory Airway Disorders
|
Dec 25 |
Here's Why NextCure, Inc. (NXTC) Looks Ripe for Bottom Fishing
|